New

Leukapheresis Market

2021

Leukapheresis Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Leukapheresis Devices and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications), and End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Transfusion Centers)

Publication Month: Aug 2021 | Report Code: TIPRE00005515 | No. of Pages: 190 | Category: Pharmaceuticals | Status: Published

Market Insights

Leukapheresis Market to Grow at a CAGR of 8.7% to reach US$ 133.90 million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The leukapheresis market is projected to reach US$ 133.90 million by 2028 from US$ 74.48 million in 2021; it is estimated to grow at a CAGR of 8.7% from 2021 to 2028.

Leukapheresis is a procedure that has white blood cells (leukocytes) involved in the body's immune response are segregated from a blood sample. It is a particular form of apheresis in which an element of blood, such as red blood cells or platelets, is obtained while the remaining blood is restored to circulation. Leukapheresis is often used to reduce very high white blood cell (WBC) counts, such as chronic blood cancers like chronic lymphocytic leukemia (CLL). It can also be completed to obtain white blood cells for later transplant, such as to manage abrupt declines in WBC counts throughout cancer chemotherapy. Another use is as a section of a novel form of immunotherapy, termed chimeric antigen receptor (CAR) T-cell therapy, to help fight leukemia, prostate cancer, and other forms of cancers. Leukapheresis can be completed on the person claiming treatment (autologous apheresis) or on a donor for a later transplant (allogeneic apheresis). Currently, leukapheresis is commonly used to treat various diseases, and it is also used for diagnostic purposes as it can increase circulating tumor cells yields. Factors such as the rising number of voluntary blood donors, increasing incidence of hematologic diseases, and surging elderly population are fueling the leukapheresis market growth. However, the high cost of leukapheresis obstructs the growth of the market to a certain extent.

Lucrative Regions for Leukapheresis Market

Lucrative Regions for Leukapheresis Market

Get more information on this report :



Market Insights

Blood transfusion is an integral part of the national health infrastructure and policies of various countries. Advancements in the medical industry have led to improvements in the treatment procedures of serious illnesses and injuries, which eventually has propelled the need for blood transfusion for patients’ survival. Growing awareness regarding the importance of blood transfusion and blood availability in healthcare services has led to rise in the number of people willing to donate their blood for medical causes. As per the World Health Organization (WHO) data, ~117.4 million blood donations were reported worldwide in 2018. Blood donors are usually classified to be voluntary unpaid, paid, and family/replacement, and as per the WHO claims, voluntary/unpaid donors are the major source of a reliable and adequate supply of blood. According to WHO data in 2019, blood donations by voluntary unpaid donors increased by 11.6 million from 2008 to 2015 in 139 countries in the world. The trend of blood donation is also gaining significant prominence in low and middle-income countries. According to the data presented during the CAG annual meeting 2017, ~13,000 procedures were performed on 1,087 patients in 2016. The greatest surge in the number of voluntary blood donors was found in Southeast Asian countries (83%) and the Americas (70%).

National programs developed and rolled out in many countries are further attracting a large number of platelet and blood donors. For example, in India, the National Blood Transfusion Council (NBTC), constituted within the National AIDS Control Organization (NACO), is the central body that coordinates with the State Blood Transfusion Councils (SBTCs),established within State AIDS Control Societies (SACS). The NBTC supports health programs for various activities related to blood transfusion services (BTS). Thus, the rising number of eligible donors in different countries across the world is fostering the need for leukapheresis equipment that is used to separate the required blood components.

Product Type-Based Insights

Based on product type, the leukapheresis market is bifurcated into leukapheresis devices and leukapheresis disposables. In 2021, the leukapheresis disposables segment held a larger market share. However, the leukapheresis devices segment is expected to register a higher CAGR during 2021 to 2028.

Leukapheresis Market, by Product Type– 2021 and 2028
Leukapheresis Market, by Product Type– 2021 and 2028

Get more information on this report :


Application-Based Insights

The leukapheresis market, by application, is bifurcated into research applications and therapeutic applications. In 2021, the research applications segment held a larger share of the market and the same segment is expected to register a higher CAGR during the coming years.

End-User-Based Insights

The leukapheresis market, by end user, is segmented into pharmaceutical and biotechnology companies, academic and research institutes, blood component providers and blood centers, and hospitals and transfusion centers. In 2021, the blood component providers and blood centers segment held the largest share of the market. On the other side, the hospitals and transfusion centers segment is expected to register the highest a CAGR during the coming years.


Strategic Insights

Companies operating in the leukapheresis market are adopting strategies such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain brand name, and meet the growing demand from end users.

Leukapheresis Market – by Product Type

  • Leukapheresis Devices
    • Apheresis Devices
    • Leukapheresis Columns and Cell Separators
    • Leukoreduction Filters
  • Leukapheresis Disposables

Leukapheresis Market – by Application

  • Research Applications
  • Therapeutic Applications

Leukapheresis Market – by End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Blood Component Providers and Blood Centres
  • Hospitals and Transfusion Centers

Leukapheresis Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
  • South America (SAM)

    • Brazil
    • Argentina
    • Rest of South and Central America

Company Profiles

  • Asahi Kasei Corporation
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • Terumo Corporation
  • STEMCELL Technologies Inc.
  • HemaCare
  • Macopharma
  • AllCells
  • STEMEXPRESS
  • BioIVT

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Leukapheresis Market – By Product Type

1.3.2 Global Leukapheresis Market – By Application

1.3.3 Global Leukapheresis Market – By End User

1.3.4 Global Leukapheresis Market – By Geography

2. Leukapheresis Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Leukapheresis Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe– PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East and Africa – PEST Analysis

4.2.5 South and Central America (SCAM) – PEST Analysis

4.3 Expert Opinions

5. Leukapheresis Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Number of Voluntary Blood Donors

5.1.2 Increasing Incidence of Hematologic Diseases

5.1.3 Surge in Elderly Population

5.2 Key Market Restraints

5.2.1 High Cost of Leukapheresis

5.3 Key Market Opportunities

5.3.1 Growth Opportunities in Emerging Economies

5.4 Future Trends

5.4.1 Developments in Therapeutic Apheresis

5.5 Impact Analysis

6. Leukapheresis Market – Global Analysis

6.1 Global Leukapheresis Market Revenue Forecast and Analysis

6.2 Global Leukapheresis Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

7. Leukapheresis Market Analysis and forecasts to 2028 – Product Type

7.1 Overview

7.2 Global Leukapheresis Market Share by Product Type 2021 & 2028 (%)

7.3 Leukapheresis Devices

7.3.1 Overview

7.3.2 Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Mn)

7.3.2.1 Apheresis Devices

7.3.2.1.1 Overview

7.3.2.1.2 Apheresis Devices Market Revenue and Forecast to 2028 (US$ Mn)

7.3.2.2 Leukapheresis Columns and Cell Separators

7.3.2.2.1 Overview

7.3.2.2.2 Leukapheresis Columns and Cell Separators Market Revenue and Forecast to 2028 (US$ Mn)

7.3.2.3 Leukoreduction Filters

7.3.2.3.1 Overview

7.3.2.3.2 Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Mn)

7.4 Leukapheresis Disposables

7.4.1 Overview

7.4.2 Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Mn)

8. Leukapheresis Market Analysis and Forecasts TO 2028 – Application

8.1 Overview

8.2 Global Leukapheresis Market Share by Application 2021 & 2028 (%)

8.3 Research Applications

8.3.1 Overview

8.3.2 Research Applications Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Therapeutic Applications

8.4.1 Overview

8.4.2 Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Mn)

9. Leukapheresis Market Analysis and Forecasts TO 2028 – End-User

9.1 Overview

9.2 Global Leukapheresis Market Share by End-User 2021 & 2028 (%)

9.3 Pharmaceutical and Biotechnology Companies

9.3.1 Overview

9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Mn)

9.4 Blood Component Providers and Blood Centers

9.4.1 Overview

9.4.2 Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Mn)

9.5 Academic and Research Institutes

9.5.1 Overview

9.5.2 Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Mn)

9.6 Hospitals and Transfusion Centers

9.6.1 Overview

9.6.2 Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Mn)

10. Global Leukapheresis Market – Geographic Analysis

10.1 North America: Leukapheresis Market

10.1.1 Overview

10.1.2 North America: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.3 North America: Leukapheresis Market, by Product type, 2019–2028 (USD Million)

10.1.3.1 North America: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.4 North America: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.5 North America: Leukapheresis Market, by End-User, 2019–2028 (USD Million)

10.1.6 North America: Leukapheresis Market, by Country, 2021 & 2028 (%)

10.1.6.1 US: Leukapheresis Market– Revenue and Forecast to 2028 (USD Million)

10.1.6.1.1 Overview

10.1.6.1.2 US: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.3 US: Leukapheresis Market, by Product type, 2019–2028 (USD Million)

10.1.6.1.3.1 US: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.6.1.4 US: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.6.1.5 US: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.6.2 Canada: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.1 Overview

10.1.6.2.2 Canada: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.3 Canada: Leukapheresis Market, by Product type, 2019–2028 (USD Million)

10.1.6.2.3.1 Canada: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.6.2.4 Canada: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.6.2.5 Canada: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.6.3 Mexico: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.1 Overview

10.1.6.3.2 Mexico: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.3 Mexico: Leukapheresis Market, by Product type – 2019–2028 (USD Million)

10.1.6.3.3.1 Canada: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.6.3.4 Mexico: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.6.3.5 Mexico: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.2 Europe: Leukapheresis Market

10.2.1 Overview

10.2.2 Europe: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)

10.2.3 Europe: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.2.3.1 Europe: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.2.4 Europe: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.2.5 Europe: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.2.6 Europe: Leukapheresis Market, by Country, 2021 & 2028 (%)

10.2.6.1 Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.1.1 Overview

10.2.6.1.2 Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.1.3 Germany: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.2.6.1.3.1 Germany: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.2.6.1.4 Germany: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.2.6.1.5 Germany: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.2.6.2 France: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.2.1 Overview

10.2.6.2.2 France: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.2.3 France: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.2.6.2.3.1 France: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.2.6.2.4 France: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.2.6.2.5 France: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.2.6.3 UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.3.1 Overview

10.2.6.3.2 UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.3.3 UK: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.2.6.3.3.1 UK: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.2.6.3.4 UK: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.2.6.3.5 UK: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.2.6.4 Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.4.1 Overview

10.2.6.4.2 Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.4.3 Italy: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.2.6.4.3.1 Italy: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.2.6.4.4 Italy: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.2.6.4.5 Italy : Leukapheresis Market, by End User, 2019-2028 (USD Million)

10.2.6.5 Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.5.1 Overview

10.2.6.5.2 Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.5.3 Spain: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.2.6.5.3.1 Spain: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.2.6.5.4 Spain: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.2.6.5.5 Spain: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.2.6.6 Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.6.1 Overview

10.2.6.6.2 Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.6.3 Rest of Europe: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.2.6.6.3.1 Rest of Europe: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.2.6.6.4 Rest of Europe: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.2.6.6.5 Rest of Europe: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.3 Asia Pacific: Leukapheresis Market

10.3.1 Overview

10.3.2 Asia Pacific: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)

10.3.3 Asia Pacific: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.3.3.1 Asia Pacific: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.3.4 Asia Pacific: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.3.5 Asia Pacific: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.3.6 Asia Pacific: Leukapheresis Market, by Country, 2021 & 2028 (%)

10.3.6.1 China: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.1.1 Overview

10.3.6.1.2 China: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.1.3 China: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.3.6.1.3.1 China: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.3.6.1.4 China: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.3.6.1.5 China: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.3.6.2 Japan: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.2.1 Overview

10.3.6.2.2 Japan: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.2.3 Japan: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.3.6.2.3.1 Japan: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.3.6.2.4 Japan: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.3.6.2.5 Japan: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.3.6.3 India: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.3.1 Overview

10.3.6.3.2 India: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.3.3 India: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.3.6.3.3.1 Canada: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.3.6.3.4 India: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.3.6.3.5 India: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.3.6.4 Australia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.4.1 Overview

10.3.6.4.2 Australia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.4.3 Australia: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.3.6.4.3.1 Australia: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.3.6.4.4 Australia: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.3.6.4.5 Australia: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.3.6.5 South Korea: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.5.1 Overview

10.3.6.5.2 South Korea: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.5.3 South Korea: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.3.6.5.3.1 South Korea: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.3.6.5.4 South Korea: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.3.6.5.5 South Korea: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.3.6.6 Rest of Asia Pacific: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.6.1 Overview

10.3.6.6.2 Rest of Asia Pacific: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.6.3 Rest of Asia Pacific: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.3.6.6.3.1 Rest of Asia Pacific: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.3.6.6.4 Rest of Asia Pacific: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.3.6.6.5 Rest of Asia Pacific: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.4 Middle East & Africa: Leukapheresis Market

10.4.1 Overview

10.4.2 Middle East & Africa: Leukapheresis Market - Revenue and Forecast to 2028 (US$ Million)

10.4.3 Middle East & Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

10.4.3.1 Middle East & Africa: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.4.4 Middle East & Africa: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.4.5 Middle East & Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.4.6 Middle East & Africa: Leukapheresis Market, by Country, 2021 & 2028 (%)

10.4.6.1 Saudi Arabia: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)

10.4.6.1.1 Overview

10.4.6.1.2 Saudi Arabia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.1.3 Saudi Arabia Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

10.4.6.1.3.1 Saudi Arabia: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.4.6.1.4 Saudi Arabia: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.4.6.1.5 Saudi Arabia Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.4.6.2 UAE: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.2.1 Overview

10.4.6.2.2 UAE: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.2.3 UAE Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

10.4.6.2.3.1 UAE: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.4.6.2.4 UAE: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.4.6.2.5 UAE Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.4.6.3 South Africa: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.3.1 Overview

10.4.6.3.2 South Africa: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.3.3 South Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

10.4.6.3.3.1 South Africa: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.4.6.3.4 South Africa: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.4.6.3.5 South Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.4.6.4 Rest of Middle East and Africa: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)

10.4.6.4.1 Overview

10.4.6.4.2 Rest of Middle East and Africa: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)

10.4.6.4.3 Rest of Middle East & Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

10.4.6.4.3.1 Rest of Middle East and Africa: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.4.6.4.4 Rest of Middle East and Africa: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.4.6.4.5 Rest of Middle East & Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.5 South and Central America: Leukapheresis Market

10.5.1 Overview

10.5.2 South and Central America: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.5.3 South and Central America: Leukapheresis Market, By Product Type, 2019–2028 (USD Million)

10.5.3.1 South and Central America Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

10.5.4 South and Central America: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.5.5 South and Central America: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.5.6 South and Central America: Leukapheresis Market, by Country, 2021 & 2028 (%)

10.5.6.1 Brazil: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.1.1 Brazil: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.1.2 Brazil: Leukapheresis Market, By Product Type, 2019–2028 (USD Million)

10.5.6.1.2.1 Brazil: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.5.6.1.3 Brazil: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.5.6.1.4 Brazil: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.5.6.2 Argentina: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.2.1 Argentina: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.2.2 Argentina: Leukapheresis Market, By Product Type, 2019–2028 (USD Million)

10.5.6.2.2.1 Argentina: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.5.6.2.3 Argentina: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.5.6.2.4 Argentina: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.5.6.3 Rest of South and Central America: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.3.1 Rest of South and Central America: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.3.2 Rest of South and Central America: Leukapheresis Market, By Product Type, 2019–2028 (USD Million)

10.5.6.3.2.1 Rest of South and Central America: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.5.6.3.3 Rest of South and Central America: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.5.6.3.4 Rest of South and Central America: Leukapheresis Market, by End User, 2019–2028 (USD Million)

11. Impact of COVID-19 Pandemic on Global Leukapheresis Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment Of COVID-19 Pandemic

11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Leukapheresis Market– Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 Asahi Kasei Corporation

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Fresenius SE & Co. KGaA

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Haemonetics Corporation

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Terumo Corporation

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 STEMCELL Technologies Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 HemaCare

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Macopharma

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 AllCells

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 STEMEXPRESS

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 BioIVT

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

Table 2. North America Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 3. North America Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4. North America Leukapheresis Market, by End-User – Revenue and Forecast to 2028 (USD Million)

Table 5. US Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

Table 6. US Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 7. US Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8. US Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. Canada Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

Table 10. Canada Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 11. Canada Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12. Canada Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. Mexico Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

Table 14. Mexico Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 15. Mexico Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16. Mexico Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17. Europe: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 18. Europe Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 19. Europe Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 20. Europe Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 21. Germany: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 22. Germany Leukapheresis Market, by D Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 23. Germany Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 24. Germany: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 25. France: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)

Table 26. France Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 27. France Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 28. France: Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 29. UK: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)

Table 30. UK Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 31. UK Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 32. UK: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 33. Italy: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 34. Italy Leukapheresis Market, by Leukapheresis Devices– Revenue and Forecast to 2028 (USD Million)

Table 35. Italy Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 36. Italy: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 37. Spain: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 38. Spain Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 39. Spain Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 40. Spain: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 41. Rest of Europe: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 42. Rest of Europe Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 43. Rest of Europe Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 44. Rest of Europe: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 45. Asia Pacific: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 46. Asia Pacific Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 47. Asia Pacific Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 48. Asia Pacific Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 49. China: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 50. China Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 51. China Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 52. China: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 53. Japan: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)

Table 54. Japan Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 55. Japan Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 56. Japan: Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 57. India: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)

Table 58. India Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 59. India Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 60. India: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 61. Australia: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 62. Australia Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 63. Australia Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 64. Australia: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 65. South Korea: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 66. South Korea Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 67. South Korea Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 68. South Korea: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 69. Rest of Asia Pacific: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 70. Rest of Asia Pacific Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 71. Rest of Asia Pacific Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 72. Rest of Asia Pacific: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 73. Middle East & Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

Table 74. Middle East & Africa Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 75. Middle East & Africa Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 76. Middle East & Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 77. Saudi Arabia Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

Table 78. Saudi Arabia Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 79. Saudi Arabia Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 80. Saudi Arabia Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 81. UAE Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

Table 82. UAE Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 83. UAE Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 84. UAE Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 85. South Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

Table 86. South Africa Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 87. South Africa Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 88. South Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 89. Rest of Middle East & Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

Table 90. Rest of Middle East and Africa Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 91. Rest of Middle East and Africa Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 92. Rest of Middle East & Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 93. South and Central America: Leukapheresis Market, By Product Type – Revenue and Forecast to 2028 (USD Million)

Table 94. South and Central America Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 95. South and Central America Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 96. South and Central America Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 97. Brazil: Leukapheresis Market, By Product Type – Revenue and Forecast to 2028 (USD Million)

Table 98. Brazil Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 99. Brazil Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 100. Brazil Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 101. Argentina: Leukapheresis Market, By Product Type – Revenue and Forecast to 2028 (USD Million)

Table 102. Argentina Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 103. Argentina Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 104. Argentina Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 105. Rest of South and Central America: Leukapheresis Market, By Product Type – Revenue and Forecast to 2028 (USD Million)

Table 106. Rest of South and Central America Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 107. Rest of South and Central America Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 108. Rest of South and Central America Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 109. Organic Developments Done by Companies

Table 110. Inorganic Developments Done by Companies

Table 111. Glossary of Terms, Leukapheresis Market

LIST OF FIGURES

Figure 1. Leukapheresis Market Segmentation

Figure 2. Leukapheresis Market Segmentation, By Region

Figure 3. Leukapheresis Market Overview

Figure 4. Leukapheresis Disposables Segment Held Largest Share of Leukapheresis Market

Figure 5. Asia Pacific to Show Significant Growth During Forecast Period

Figure 6. Leukapheresis Market, by Geography (US$ Million)

Figure 7. Global Leukapheresis Market – Leading Country Markets (US$ Million)

Figure 8. Global Leukapheresis Market, Industry Landscape

Figure 9. North America PEST Analysis

Figure 10. Europe and PEST Analysis

Figure 11. Asia Pacific PEST Analysis

Figure 12. Middle East and Africa PEST Analysis

Figure 13. South and Central America (SCAM) PEST Analysis

Figure 14. Leukapheresis market impact analysis of driver and restraints

Figure 15. Global Leukapheresis Market – Revenue Forecast and Analysis – 2020- 2028

Figure 16. Global Leukapheresis Market – By Geography Forecast and Analysis – 2021- 2028

Figure 17. Market Positioning of Key Players in Global Leukapheresis Market

Figure 18. Global Leukapheresis Market Share by Product Type 2021 & 2028 (%)

Figure 19. Leukapheresis Devices Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. Apheresis Devices Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. Leukapheresis Columns and Cell Separators Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. Leukoreduction Filters Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. Leukapheresis Disposables Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. Global Leukapheresis Market Share by Application 2021 & 2028 (%)

Figure 25. Research Applications Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. Therapeutic Applications Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27. Global Leukapheresis Market Share by End-User 2021 & 2028 (%)

Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. Blood Component Providers and Blood Centers Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30. Academic and Research Institutes Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31. Hospitals and Transfusion Centers Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 32. North America: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)

Figure 33. North America Leukapheresis Market Revenue and Forecast to 2028 (USD Million)

Figure 34. North America: Leukapheresis Market, by Country, 2021 & 2028 (%)

Figure 35. US: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 36. Canada: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 37. Mexico: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 38. Europe: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)

Figure 39. Europe Leukapheresis Market Revenue and Forecast to 2028 (USD Million)

Figure 40. Europe: Leukapheresis Market, by Country, 2021 & 2028 (%)

Figure 41. Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 42. France: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 43. UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 44. Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 45. Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 46. Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 47. Asia Pacific: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)

Figure 48. Asia Pacific Leukapheresis Market Revenue and Forecast to 2028 (USD Million)

Figure 49. Asia Pacific: Leukapheresis Market, by Country, 2021 & 2028 (%)

Figure 50. China: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 51. Japan: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 52. India: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 53. Australia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 54. South Korea: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 55. Rest of Asia Pacific: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 56. Middle East & Africa: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)

Figure 57. Middle East & Africa Leukapheresis Market Revenue and Forecast to 2028 (USD Million)

Figure 58. Middle East & Africa: Leukapheresis Market, by Country, 2021 & 2028 (%)

Figure 59. Saudi Arabia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 60. UAE: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 61. South Africa: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 62. Rest of Middle East and Africa: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)

Figure 63. South and Central America: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)

Figure 64. South and Central America Leukapheresis Market Revenue and Forecast to 2028 (USD Million)

Figure 65. South and Central America: Leukapheresis Market, by Country, 2021 & 2028 (%)

Figure 66. Brazil: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 67. Argentina: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 68. Rest of South and Central America: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 1. Impact of COVID-19 Pandemic in North American Country Markets

Figure 2. Impact of COVID-19 Pandemic in European Country Markets

Figure 3. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 4. Impact Of COVID-19 Pandemic In Middle East and Africa Market

Figure 5. Impact Of COVID-19 Pandemic In South and Central America Market

Figure 6. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - Leukapheresis Market

  1. Asahi Kasei Corporation
  2. Fresenius SE & Co. KGaA
  3. Haemonetics Corporation
  4. Terumo Corporation
  5. STEMCELL Technologies Inc.
  6. HemaCare
  7. Macopharma
  8. AllCells
  9. STEMEXPRESS
  10. BioIVT
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the leukapheresis market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global leukapheresis market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00005515
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Leukapheresis is a procedure that has white blood cells (leukocytes) involved in the body's immune response are segregated from a blood sample. It is a particular form of apheresis in which an element of blood, such as red blood cells or platelets, is obtained while the remaining blood is restored to circulation. Leukapheresis is often used to reduce very high white blood cell (WBC) counts, such as chronic blood cancers like chronic lymphocytic leukemia (CLL). It can also be completed to obtain white blood cells for later transplant, such as to manage abrupt declines in WBC counts throughout cancer chemotherapy. Another use is as a section of a novel form of immunotherapy, termed chimeric antigen receptor (CAR) T-cell therapy, to help fight leukemia, prostate cancer, and other forms of cancers. Leukapheresis can be completed on the person claiming treatment (autologous apheresis) or on a donor for a later transplant (allogeneic apheresis). Currently, leukapheresis is commonly used to treat various diseases, and it is also used for diagnostic purposes as it can increase circulating tumor cells yields.

Key factors that are driving the growth of this market are number of voluntary blood donors, increasing incidence of hematologic diseases, surge in elderly population and growing demand for leukopaks in clinical research activities boost the market growth over the years.

The leukapheresis disposables segment dominated the global leukapheresis market and held the largest revenue share of 61.43% in 2021.

The blood component providers and blood centers segment dominated the global leukapheresis market and accounted for the largest revenue share of 35.03% in 2021.

The leukapheresis market majorly consists of the players such Asahi Kasei Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation Terumo Corporation, STEMCELL Technologies Inc., HemaCare, Macopharma, AllCells, STEMEXPRESS, and BioIVT amongst others.

Global leukapheresis market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for leukapheresis. The growth of the region is attributed to increasing product launches coupled with increasing patient population. The Asia Pacific region is expected to account for the fastest growth in the leukapheresis market. Increase in government investments and a number of private biotechnology companies in this region contribute to this dominant share. The rising geriatric population and increasing investment in research are said to be responsible for this growth.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.